ntuitive Surgical (Nasdaq: ISRG)+
announced today that it received FDA clearance for new software advancements for its Ion endoluminal robot.
SALT LAKE CITY, Oct. 7, 2025 /PRNewswire/ — Xenocor, Inc., a leader in single-use surgical visualization, proudly announces the issuance of U.S. Patent No. 12,429,685 B2 for its innovative medical borescope and tip assembly technology. This milestone reinforces Xenocor’s commitment to advancing safe, efficient, and accessible minimally invasive procedures through disposable and digitally optimized laparoscopic tools.
A major cardiovascular risk factor is thickening of the heart walls (hypertrophy), which can result from high blood pressure—but is also linked to inherited diseases of the heart which can lead to sudden death.
Scientists at the University of East Anglia and Oxford Biodynamics have developed a high accuracy blood test to diagnose chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME/CFS).
In lieu of animal experiments, researchers from the University of Rochester are using state-of-the-art microchips with human tissue to better understand how the brain operates under healthy conditions and is damaged through neurodegenerative diseases or conditions like sepsis.
Engineering and health researchers at the University of Waterloo have developed a radar and artificial intelligence (AI) system that can monitor multiple people walking in busy hospitals and long-term care facilities to identify possible health issues.
Remedy Robotics announced that it debuted the N1 system, a remotely operable endovascular surgical robotic system.
Vektor Medical today announced it received CE mark approval for its vMap artificial intelligence-powered arrhythmia mapping system.
Medtronic (NYSE: MDT)+
today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device.
Medtronic (NYSE: MDT)+
announced today that it kicked off the European launch of its VitalFlow one-system ECMO solution.